Shortly after locking down a world-first approval in China, Bayer is bringing its groundbreaking stroke prevention drug ...

Eli Lilly could soon see two label expansions for Foundayo, it’s oral GLP-1, in swift succession: In September, the drugmaker ...

In a new readout of 12-month data, Veradermics' oral minoxidil delivered the best hair growth data of its phase 3 program so ...

Johnson & Johnson’s much-hyped Icotyde pill shows another biologic-like efficacy in inflammatory diseases, with a phase 3 win ...

The FDA has launched a safety investigation into Novartis’ gene therapy Zolgensma following reports of tumors in patients, as ...

Sticking by the strong relationship Moderna has fostered with the United Kingdom, the mRNA specialist is relocating its home base in the country to a different part of the capital.  | Sticking by the ...

After playing a key role in sparking a new era in cancer treatment through its work in antibody drug conjugates (ADCs), Daiichi Sankyo is pursuing an even bigger ambition: to shape what comes next in ...

Against a backdrop of repeated industry challenges in court, the Centers for Medicare and Medicaid Services (CMS) is locking ...

AstraZeneca may not need a major acquisition to sustain growth beyond 2030—but the British pharma is reportedly not stopping ...

ViiV Healthcare has tapped a new mind for its “PrEP Wisdom” campaign, with Tony Award-winning actor and fashion icon Jeremy ...

Amid surging sales of Rezdiffra, Madrigal Pharmaceuticals is facing a whistleblower lawsuit alleging that senior leadership ...

Knudsen’s departure will mark the end of a 27-year run at Novo, with Doustdar telling analysts Wednesday that the outgoing ...